Azarga Indication
I cannot provide the indication for "Azarga" as the evidence provided pertains exclusively to valsartan (an angiotensin receptor blocker) and amlodipine/valsartan combinations for hypertension and heart failure—not Azarga, which is a completely different medication (brinzolamide/timolol ophthalmic suspension for glaucoma).
Critical Clarification
There appears to be a fundamental mismatch between your question and the evidence provided:
Azarga is an ophthalmic (eye drop) medication containing brinzolamide (a carbonic anhydrase inhibitor) and timolol (a beta-blocker) used to reduce intraocular pressure in glaucoma and ocular hypertension.
The evidence provided discusses valsartan (an ARB) and amlodipine/valsartan combinations for systemic hypertension and cardiovascular conditions.
If You Meant Amlodipine/Valsartan Combination
Amlodipine/valsartan single-pill combination is indicated for the treatment of hypertension in adults to lower blood pressure, thereby reducing the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions 1.
Specific FDA-Approved Indications for Valsartan (Component)
Per FDA labeling, valsartan is indicated for 1:
- Hypertension: Treatment in adults and pediatric patients ≥1 year of age to lower blood pressure
- Heart Failure: Reduce risk of hospitalization in adults with heart failure (NYHA class II-IV)
- Post-Myocardial Infarction: Reduce cardiovascular mortality in clinically stable adults with left ventricular failure or dysfunction following MI
When to Use Amlodipine/Valsartan Combination
Use this combination in patients whose blood pressure is not adequately controlled on monotherapy with either component, or as initial therapy in patients likely to need multiple drugs to achieve BP goals 1, 2.
The 2024 ESC Guidelines strongly support this approach, recommending combination therapy as initial treatment for most patients with confirmed hypertension (BP ≥140/90 mmHg), preferably using a RAS blocker (like valsartan) with a dihydropyridine calcium channel blocker (like amlodipine) as a fixed-dose single-pill combination 3.
Clinical Advantages
- Superior efficacy: Achieves greater BP reduction than either monotherapy 4, 2, 5
- Reduced side effects: Valsartan significantly reduces amlodipine-induced peripheral edema 4, 6, 5
- Improved adherence: Single-pill combination simplifies treatment 3, 2
Please clarify if you intended to ask about Azarga (the glaucoma medication) or amlodipine/valsartan (the hypertension medication), as these are entirely different drugs with different indications.